Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of BI 1815368 pharmacokinetics in healthy men
NL-OMON61312Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of BI 1815368, sponsored by Boehringer Ingelheim. Started Jul 2026; status: completed.
02
Drugs
BI 1815368
Beyond the preview
Go deeper on NL-OMON61312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61312.